Akero Therapeutics
AKRO
AKRO
102 hedge funds and large institutions have $888M invested in Akero Therapeutics in 2020 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 40 increasing their positions, 23 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
7.3% more ownership
Funds ownership: 76.24% → 83.54% (+7.3%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
79% less call options, than puts
Call options by funds: $289K | Put options by funds: $1.4M
Holders
102
Holding in Top 10
3
Calls
$289K
Puts
$1.4M
Top Buyers
| 1 | +$59.9M | |
| 2 | +$54.9M | |
| 3 | +$39.5M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$24.5M |
| 5 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
+$18.5M |
Top Sellers
| 1 | -$41.2M | |
| 2 | -$21.7M | |
| 3 | -$9.29M | |
| 4 |
Morgan Stanley
New York
|
-$3.97M |
| 5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$2.37M |